Daily News Archive
Daily News Subscription
US Salix-Free Racing Faces Setback
Despite wide ranging efforts to ultimately create Salix-free racing in the US, there was a further setback when, according to thoroughbredtimes.com, the "National Horsemen's Benevolent and Protective Association reported that 24 of its state affiliates, representing 29,000 Thoroughbred owners and trainers, have passed formal board resolutions supporting the continued use of race-day Salix to prevent exercise-induced pulmonary hemorrhage." This is in contrast to a release in recent weeks by the Thoroughbred Owners And Breeders Association divulging the names of 40 owners "who have pledged not to race their juveniles on Salix this year". Used to control bleeding, in June US regulators were examining the Kentucky Horse Racing Commission's move to phase out use of race-day furosemide (also called Salix or Lasix) in graded & listed stakes beginning in 2014. "The scientific research incontestably establishes that [Salix] allows a horse to only run to its God-given potential; not faster than its potential" claimed National HBPA chief executive Phil Hanrahan.